Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from PR Newswire

02:52 EST 9th December 2019 | BioPortfolio

Here are the most relevant search results for "PR Newswire" found in our extensive news archives from over 250 global news sources.

More Information about PR Newswire on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PR Newswire for you to read. Along with our medical data and news we also list PR Newswire Clinical Trials, which are updated daily. BioPortfolio also has a large database of PR Newswire Companies for you to search.

Showing News Articles 1–25 of 378 from PR Newswire

Friday 6th December 2019

Korean ophthalmologist Oh Jungwoo performed '25 sec LASEK' in public for the first time

- Reduces surgical time and decreases cornea damage by 40%, effective and safe surgery with laser only procedure SEOUL, South Korea, Dec. 6, 2019 /PRNewswire/ -- Dr. Oh Jungwoo from Eos Eye Center in Gangnam-gu, Korea, revealed '25 sec LASEK' surgery publicly by video. This is the first time the operation has been released to the public and it shows Dr. Oh's ...

PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided

HONG KONG, Dec. 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported that China's National Health Commission ("NHC") recently issued a new policy allowing the relevant Provincial Health Commissions ...

CStone appoints seasoned pharmaceutical executive Shirley Zhao as the General Manager for Greater China and Head of Commercial

SUZHOU, China, Dec. 6, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced the appointment of Ms. Shirley Zhao to the position of General Manager for Greater China and Head of Commercial. In this position, Ms. Zhao will be responsible for the commercialization of the Company's products and will report directly to Dr. Frank Ji...

CNN's 'Vital Signs with Dr. Sanjay Gupta' explores Traditional Chinese Medicine in Hong Kong

HONG KONG, Dec. 6, 2019 /PRNewswire/ -- There are few places in the world where modern and traditional intersect quite like Hong Kong, so what better place to explore the world of Traditional Chinese Medicine and ancient lifestyle practices. This month on CNN's 'Vital Signs' Dr. Sanjay Gupta travels to Hong Kong to experience Traditional Chinese Medicine first-hand and explore how it fits into tod...

Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-LAG-3 Monoclonal Antibody in China

SUZHOU, China, Dec. 6, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today announced that the first patient has been successfully dosed in a Phase I clinical tr...

Thursday 5th December 2019

Global Cord Blood Corporation Announces Results of 2019 Annual General Meeting

HONG KONG, Dec. 5, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2019 Annual General Meeting, which was held on December 5, 2019, in Hong Kong S.A.R...

Announcement of collaborative research agreement with National Cancer Center on analysis of gut bacteria related to cancer

TOKYO, Dec. 5, 2019 /PRNewswire/ -- bitBiome, Inc. (Representative Director: Yoshihito Daimon, "bitBiome") and National Cancer Center of Japan (President: Hitoshi Nakagama, Chuo-ku, Tokyo, "NCC") have signed a collaborative research agreement on the analysis of gut bacteria related to cancer on November 22nd. This collaborative research is an incidental study in the third phas...

Mayapada Clinic Accomplished Plenary Level Certification from the Accreditation Commission of the Ministry of Health

The First Certified Private Primary Clinic in South Jakarta JAKARTA, Indonesia, Dec. 5, 2019 /PRNewswire/ -- Mayapada Clinic, which is part of Mayapada Healthcare, has accomplished Plenary Level Passed Certification from the First Level Health Facilities Accreditation Commission (FKTP- Fasilitas Kesehatan Tingkat Pertama) from Ministry of Health, Indones...

Hummingbird Bioscience Raises US$19 Million in Series B Financing

Fundraising will support the expansion of Hummingbird Bioscience's discovery pipeline and rapid development of its portfolio of targeted antibody therapeutics SINGAPORE, Dec. 5, 2019 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrough precision a...

Biocon Biologics Takes Forward its Mission to Unlock Universal Access to Insulins Globally

BUSAN, South Korea, Dec. 5, 2019 /PRNewswire/ -- Biocon Biologics, a fully integrated 'pure play' global biosimilars organisation, is taking forward its mission of unlocking affordable access to quality insulins for people with diabetes across the world. As a credible, global insulins player, it is committed to address the growing healthcare

Wednesday 4th December 2019

Huami Corporation Announced Corporate Mission: Connect Health with Technology

Recaps 2019 Accomplishments and Looks to 2020 and Beyond BEIJING, Dec. 4, 2019 /PRNewswire/ -- Huami Corporation ("Huami" or the "Company") (NYSE: HMI), a biometric and activity data-driven company with significant expertise in smart wearable technology, today hosted an annual press conference in Beijing, focusing on strategies. Durin...

FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis Bullosa

BALERNA, Switzerland, Dec. 4, 2019 /PRNewswire/ -- APR Applied Pharma Research sa ("APR"), the Swiss pharma company focused in niche and rare therapeutic areas, announces that the US Food and Drug Administration (the "FDA") has gran

Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK), one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck, a leading science and technology company. In line with the Healthy China Initiative (2019-2030), the two companies will jointly explore...

Ping An Good Doctor and Merck KGaA, Darmstadt, Germany Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK) one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck KGaA, Darmstadt, Germany, a leading science and technology company. In line with the Healthy China Initiative (2019-2030), the two compan...

Accor releases thought-leading white paper on the business of wellness and hospitality

In "It's a Wellness World: The Global Shift Shaking up Our Business", Accor's Emlyn Brown explains how exceptional wellness experiences are good for guests, business and the hospitality industry SIEM REAP, Cambodia, Dec. 4, 2019 /PRNewswire/ -- When stepping into a hotel these days, one cannot help but notice a growing wave of smoothie bowls, pilates pos...

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK). In line with the Healthy China Initiative (2019-2030), the two companies will jointly explo...

TIENS Group Featured on the NASDAQ Screen in New York's Times Square

TIANJIN, China, Dec. 4, 2019 /PRNewswire/ -- TIENS Group, one of the world's leading healthcare companies, appeared on the NASDAQ screen in New York's Times Square on November 18, 2019 to display the charm of Chinese enterprise to the world. TIENS Group Featured on the NASDAQ

Celebrate 2019 Rice Day with HealthyRicestyle: Jasmine Food Highlights a Fun and Healthy Way to Enjoy Rice

PUCHONG and SELANGOR, Malaysia, Dec. 4, 2019 /PRNewswire/ -- Jasmine Food Corporation ends 2019 Rice Day with successful wrap up of 'HealthyRiceStyle 2019', captivating thousands of visitors to join the rice-related activities at North Court, IOI Mall Puchong, Malaysia. Aiming to enrich Malaysian consumers on the benefits of consuming rice, the campaign was the first to portray seven var...

Tuesday 3rd December 2019

Ping An Receives Two Awards from Hong Kong Institute of Directors

HONG KONG and SHANGHAI, Dec. 3, 2019 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) has received two awards at the Directors Of The Year Awards 2019, organized by the Hong Kong Institute of Directors. Ping An's Board of Directors won the Board award in the Listed Companies Boards category for its outs...

Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US

TAIPEI, Dec. 3, 2019 /PRNewswire/ -- Opioid misuse, addiction, and overdoses have caused significant social and economic burdens leading to the opioid crisis. LT1001 (brand name Naldebain®) is a prodrug of nalbuphine, an abuse-free analgesic that has been marketed worldwide for decades. Naldebain® is developed by Lumosa Therapeutics ("Lumosa;" 6535.TWO) as the world's first exten...

Continuing the Resplendence with 20 Years' Glory, CPhI China Welcomes the Golden Year of Chinese Pharma

SHANGHAI, Dec. 3, 2019 /PRNewswire/ -- As a world-renowned vertical trade and exchange event of the pharmaceutical industry, CPhI & P-MEC China 2020 will take place at Shanghai New International Expo Centre (SNIEC) June 22-24, 2020. The exhibition will reach a scale of 210,000m2, facilitate over 3,400 Chinese and overseas exhibitors to showcase innovative products and advanced technologies, an...

QBiotics Announces First Patient Dosed in its Phase I/II Clinical Trial of Tigilanol Tiglate for Head and Neck Cancer

First patient successfully dosed in QBiotics' Phase I/II clinical trial of tigilanol tiglate in patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Tigilanol tiglate is a novel, small molecule that is being tested as a single injection treatment for solid tumours The Phase I/II clinical trial is a dose escalation study in HNSCC patients designed to determine optimal dosage, safety...

New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority

NERLYNX® (neratinib) now approved in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy NERLYNX is the first therapy in the Specialised Therapeutics' portfolio approved in SE Asia Five-year follow up data show NERLYNX reduces risk of invasive disease recurrence by 42% in women with early-stage, HER2+/HR+ breast cancer and who commence therapy withi...

Monday 2nd December 2019

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project The first in class biologic was independently discovered and developed by Fapon Biopharma and shows s...

Concord Medical Announces Changes to the Board

BEIJING, Dec. 2, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, today announced the resignation of Mr. Shang Yan Chuang as director of the Company. Mr. Chuang submitted his resignation to ...


Quick Search

News Quicklinks